243 related articles for article (PubMed ID: 19955088)
1. Quantitative nuclear proteomics identifies mTOR regulation of DNA damage response.
Bandhakavi S; Kim YM; Ro SH; Xie H; Onsongo G; Jun CB; Kim DH; Griffin TJ
Mol Cell Proteomics; 2010 Feb; 9(2):403-14. PubMed ID: 19955088
[TBL] [Abstract][Full Text] [Related]
2. ATM-dependent and -independent dynamics of the nuclear phosphoproteome after DNA damage.
Bensimon A; Schmidt A; Ziv Y; Elkon R; Wang SY; Chen DJ; Aebersold R; Shiloh Y
Sci Signal; 2010 Dec; 3(151):rs3. PubMed ID: 21139141
[TBL] [Abstract][Full Text] [Related]
3. Human PTIP facilitates ATM-mediated activation of p53 and promotes cellular resistance to ionizing radiation.
Jowsey PA; Doherty AJ; Rouse J
J Biol Chem; 2004 Dec; 279(53):55562-9. PubMed ID: 15456759
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways.
Rappold I; Iwabuchi K; Date T; Chen J
J Cell Biol; 2001 Apr; 153(3):613-20. PubMed ID: 11331310
[TBL] [Abstract][Full Text] [Related]
5. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
Rui YN; Xu Z; Chen Z; Zhang S
Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
[TBL] [Abstract][Full Text] [Related]
6. Polo-like kinase 1 inhibits DNA damage response during mitosis.
Benada J; Burdová K; Lidak T; von Morgen P; Macurek L
Cell Cycle; 2015; 14(2):219-31. PubMed ID: 25607646
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage.
Anderson L; Henderson C; Adachi Y
Mol Cell Biol; 2001 Mar; 21(5):1719-29. PubMed ID: 11238909
[TBL] [Abstract][Full Text] [Related]
8. Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.
Ha K; Fiskus W; Rao R; Balusu R; Venkannagari S; Nalabothula NR; Bhalla KN
Mol Cancer Ther; 2011 Jul; 10(7):1194-206. PubMed ID: 21566061
[TBL] [Abstract][Full Text] [Related]
9. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
Jacquemont C; Taniguchi T
Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
[TBL] [Abstract][Full Text] [Related]
10. A chemical genetic screen for mTOR pathway inhibitors based on 4E-BP-dependent nuclear accumulation of eIF4E.
Livingstone M; Larsson O; Sukarieh R; Pelletier J; Sonenberg N
Chem Biol; 2009 Dec; 16(12):1240-9. PubMed ID: 20064434
[TBL] [Abstract][Full Text] [Related]
11. A proteomic analysis of ataxia telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints.
Mu JJ; Wang Y; Luo H; Leng M; Zhang J; Yang T; Besusso D; Jung SY; Qin J
J Biol Chem; 2007 Jun; 282(24):17330-4. PubMed ID: 17478428
[TBL] [Abstract][Full Text] [Related]
12. RNF8-dependent and RNF8-independent regulation of 53BP1 in response to DNA damage.
Sakasai R; Tibbetts R
J Biol Chem; 2008 May; 283(20):13549-55. PubMed ID: 18337245
[TBL] [Abstract][Full Text] [Related]
13. Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status.
Nagata Y; Takahashi A; Ohnishi K; Ota I; Ohnishi T; Tojo T; Taniguchi S
Int J Oncol; 2010 Oct; 37(4):1001-10. PubMed ID: 20811722
[TBL] [Abstract][Full Text] [Related]
14. The PCPH oncoprotein antagonizes the proapoptotic role of the mammalian target of rapamycin in the response of normal fibroblasts to ionizing radiation.
Tirado OM; Mateo-Lozano S; Sanders S; Dettin LE; Notario V
Cancer Res; 2003 Oct; 63(19):6290-8. PubMed ID: 14559816
[TBL] [Abstract][Full Text] [Related]
15. Protein-protein interactions occur between p53 phosphoforms and ATM and 53BP1 at sites of exogenous DNA damage.
Al Rashid ST; Harding SM; Law C; Coackley C; Bristow RG
Radiat Res; 2011 May; 175(5):588-98. PubMed ID: 21361779
[TBL] [Abstract][Full Text] [Related]
16. Dual inhibition of akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple myeloma.
Cirstea D; Hideshima T; Rodig S; Santo L; Pozzi S; Vallet S; Ikeda H; Perrone G; Gorgun G; Patel K; Desai N; Sportelli P; Kapoor S; Vali S; Mukherjee S; Munshi NC; Anderson KC; Raje N
Mol Cancer Ther; 2010 Apr; 9(4):963-75. PubMed ID: 20371718
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the role of mTOR: lessons from mTOR inhibitors.
Dowling RJ; Topisirovic I; Fonseca BD; Sonenberg N
Biochim Biophys Acta; 2010 Mar; 1804(3):433-9. PubMed ID: 20005306
[TBL] [Abstract][Full Text] [Related]
18. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
[TBL] [Abstract][Full Text] [Related]
19. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
Shaw RJ
Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
[TBL] [Abstract][Full Text] [Related]
20. Ataxia-telangiectasia mutated (ATM) participates in the regulation of ionizing radiation-induced cell death via MAPK14 in lung cancer H1299 cells.
Liang N; Zhong R; Hou X; Zhao G; Ma S; Cheng G; Liu X
Cell Prolif; 2015 Oct; 48(5):561-72. PubMed ID: 26269117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
